Escherichia coli is a commensal of the vertebrate gut that is increasingly involved in various
intestinal and extra-intestinal infections as an opportunistic pathogen. Numerous pathotypes …

Escherichia coli ST1193 is an emerging global multidrug (MDR) high-risk clone and an
important cause of community-onset urinary and bloodstream infections. ST1193 is imitating …

Quantitative evidence for the risk of zoonoses and the spread of antimicrobial resistance
remains lacking. Here, as part of the UrbanZoo project, we sampled Escherichia coli from …

The proliferation of antibiotic-resistant bacteria in the environment has potential negative
economic and health consequences. Thus, previous investigations have targeted wild …

Colistin drug resistance is an emerging public health threat worldwide. The adaptability,
existence and spread of colistin drug resistance in multiple reservoirs and ecological …

The Australian silver gull is an urban-adapted species that frequents anthropogenic waste
sites. The enterobacterial flora of synanthropic birds often carries antibiotic resistance …

To win the battle against resistant, pathogenic bacteria, novel classes of anti-infectives and
targets are urgently needed. Bacterial uptake, distribution, metabolic and efflux pathways of …

The role of wildlife with long-range dispersal such as gulls in the global dissemination of
antimicrobial resistance (AMR) across natural and anthropogenic aquatic environments …

Escherichia coli ST131 is a globally dispersed extraintestinal pathogenic E. coli lineage
contributing significantly to hospital and community acquired urinary tract and bloodstream …

Escherichia coli sequence types 131 (ST131) and 1193 are multidrug-resistant
extraintestinal pathogens that have recently spread epidemically among humans and are …